Most AI health tools are only as good as the data they’re trained on, and in Canada, as in most countries, that data has historically been locked inside hundreds of separate hospital systems that don’t talk to each other. A new national platform called Vital is trying to change that. Backed by more than $210 million in combined federal, provincial and institutional funding, Vital launched publicly on June 23, 2026, at St. Michael’s Hospital in Toronto, with an initial phase connecting near real-time data from 160 hospitals across Alberta, Ontario and Quebec.
Who built it and why
Vital was co-founded by Dr. Amol Verma and Dr. Fahad Razak, physicians at St. Michael’s, a site of Unity Health Toronto, who now serve as the platform’s national co-leads. It builds directly on Ontario’s existing GEMINI program, which already collects clinical and administrative data from more than 30 hospitals covering over 60 percent of the province’s inpatient care. Vital extends that model nationally, aiming to create a data layer that can underpin clinical AI development, support large-scale clinical trials, and attract both domestic and international research partnerships that need access to data at a scale no single hospital can offer.
Where the money comes from
The funding picture is layered. Canada’s new federal AI strategy, announced by Prime Minister Mark Carney, provides $100 million specifically to expand Vital nationally, building on $110 million already secured from federal, provincial and institutional sources — bringing total backing past $210 million. Vital separately secured $24.5 million from the Canada Foundation for Innovation in 2025 for a $68 million project to extend the platform into rural hospitals and integrate medical imaging data. The federal strategy also separately allocated $100 million toward a broader Health Sector Data Space, a distinct initiative that shouldn’t be conflated with Vital’s own funding.
What the data is actually for
The pitch is that near real-time hospital data, standardized across provinces, lets researchers and AI developers build and validate clinical tools against much larger and more diverse patient populations than any single hospital system could provide — reducing the risk that an algorithm trained on one hospital’s patients performs poorly elsewhere. Unity Health Toronto says the platform is establishing what it calls strong ethical oversight and privacy protection specifically designed to allow responsible partnerships with private-sector AI developers without compromising patient confidentiality.
The privacy tension underneath the promise
That framing — enabling private-sector partnerships while protecting privacy — is exactly where critics expect friction. Centralizing hospital data at national scale, even de-identified, raises the kind of re-identification and commercial-use concerns that have dogged similar health-data consolidation efforts elsewhere, including past controversies over NHS data-sharing deals with technology companies in the UK. Canadian privacy advocates have not yet mounted organized opposition to Vital specifically, but the platform’s stated ambition to attract “domestic and international research partnerships” leaves open exactly which private companies will eventually get access, and under what terms.
A launch with real institutional weight behind it
The public launch event drew roughly 250 participants from academia, industry and government, including Evan Solomon, Canada’s Minister of Artificial Intelligence and Digital Innovation — a sign the federal government is treating Vital as a flagship piece of its broader AI strategy rather than a niche research project.
What’s next
Vital’s initial phase covers three provinces; the harder test will be whether it can extend to the rest of Canada’s fragmented, provincially run health systems, each with its own legacy IT and privacy rules. The rural hospital expansion funded by the Canada Foundation for Innovation grant will be an early indicator of whether the platform can scale beyond large urban academic hospitals. Researchers and AI developers will be watching for Vital’s first published studies or clinical tools built on the pooled data — the real proof of whether this infrastructure investment translates into better care rather than just a bigger database. Verma and Razak have said they intend to publish governance details and early research findings on a rolling basis, which privacy advocates and health researchers alike say will be the clearest signal of whether Vital lives up to its stated balance between enabling AI innovation and protecting the patients whose records make that innovation possible.
Photo: Parentingupstream / PIXABAY via Pixabay
